Pfizer Inc. has agreed to buy Metsera Inc. in a $10 billion deal, following a heated bidding war with Novo Nordisk A/S for ...

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...

Novo Nordisk A/S has again increased its offer for Metsera Inc. as its takeover battle with Pfizer Inc. for the obesity ...

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera.

Novo Nordisk’s CEO won’t comment on whether the Danish company will go even higher in its bidding war for Metsera, but said ...

Pfizer Inc said on Monday it has filed a second lawsuit against drug developer Metsera , its controlling shareholder, and ...

The Federal Trade Commission has raised concerns about Novo Nordisk’s attempt to outbid Pfizer to acquire obesity startup ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

Another quarterly earnings announcement from Novo Nordisk and another downgrade to earnings guidance from the Danish ...

Novo Nordisk ups its bid to acquire Metsera, intensifying the obesity drug market race and challenging Pfizer.

The new offer from Novo Nordisk constitutes a superior company proposal, Metsera says.

Novo Nordisk's $10 billion bid for Metsera, an obesity drug developer, is embroiled in legal scrutiny over potential U.S. antitrust law violations. As Pfizer and Novo vie for Metsera, the FTC warns of ...